Last reviewed · How we verify
NCT03821207
The Effect of Abdominal Massage and Exercise on Primary Dysmenorrhea in University Students
NA trial testing The exercise group in Primary Dysmenorrhea in 22 participants. Completed in 2 July 2019.
6 June 2019
Quick facts
| Lead sponsor | Aydin Adnan Menderes University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 22 |
| Start date | 6 December 2018 |
| Primary completion | 6 June 2019 |
| Estimated completion | 2 July 2019 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- The exercise group
- The abdominal massage group
- Control Group — full drug profile →
Conditions studied
- Primary Dysmenorrhea — all drugs for Primary Dysmenorrhea →
Sponsor
Aydin Adnan Menderes University
Who can join
Adults 18 to 20, female only, with Primary Dysmenorrhea. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study will planing to determine the advantages of abdominal massage and exercise on primary dysmenorrhea in university students, and to evaluate whether one of these applications is superior to the other.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Exercise for dysmenorrhoea.
Armour M, Ee CC, Naidoo D, Ayati Z, et al · · 2019 · cited 57× · PMID 31538328 · DOI 10.1002/14651858.cd004142.pub4
Verify or expand the search:
- PubMed search for NCT03821207
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of The exercise group
Trials testing the same drug.
- NCT04104906 — Motor Control Training in Individuals With Subacromial Pain Syndrome · NA · completed
Other recruiting trials for Primary Dysmenorrhea
Currently open trials in the same condition.
- NCT07409337 — Self-Acupressure for Primary Dysmenorrhea and Premenstrual Symptoms · NA · recruiting
- NCT06995287 — Evaluation of the Analgesic Effect of Intramyometrial Botulinum Toxin Injection Via Hysteroscopy in Severe Primary Dysme · Phase 3 · recruiting
- NCT07352982 — Transcutaneous Tibial Nerve Stimulation on Women With Primary Dysmenorrhea · NA · recruiting
- NCT07239232 — "Knee Joint Position Sense and Dynamic Balance in Females With Primary Dysmenorrhea · recruiting
- NCT07314021 — Primary Dysmenorrhea and Mobilization. · NA · active not recruiting
Other Aydin Adnan Menderes University trials
Trials by the same sponsor.
- NCT07535151 — The Study Aims to Determine the Effect of Using Animal-shaped Magic Mirrors During Vaccination in Children Aged 1-4 Year · not yet recruiting
- NCT07448246 — Effect of Bilateral Rhomboid Intercostal Block on Postoperative Pain After Breast Implant Surgery · NA · recruiting
- NCT07317492 — HEMOVAR Study on Hemorrhoids and Varicose Veins · recruiting
- NCT07121699 — The Role of Left Ventricular Outflow Tract (LVOT) Velocity-time Integral (VTI) and Respiratory Variability at Peak Rate · not yet recruiting
- NCT07044739 — Information on the Use of Anti-embolic Stockings in Patients Undergoing Vein Surgery · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03821207 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Aydin Adnan Menderes University
- Last refreshed: 5 July 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03821207.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing